Skip to main content
🚚 Free EU & UK shipping over €300🎁 10% OFF first order - code LAUNCH10🧪 Purity Tested · ≥99% Purity📋 Certificate of Analysis available

RUO buyer guide

Where to buy Melanotan-2 for research in Europe

Melanotan-2 is supplied by Peptra Labs as melanocortin receptor peptide research material. It is positioned only for laboratory research workflows, especially melanocortin receptor and pigmentation-pathway research.

Buying Melanotan-2: what to verify

  • RUO-only positioning, with no human-use, treatment, cosmetic, or veterinary claims.
  • Sealed and clearly labelled vial or bottle, including visible product and batch identifiers.
  • Purity testing and batch-level CoA information online where applicable, not as a printed document in the parcel.
  • Clear supplier identity, research policy, shipping notes, and refund/payment terms.
  • Internal links between product, peptide education, lab reports, and quality policy pages.

Peptra source graph

Use these sources together before ordering Melanotan-2:

Research context

Melanotan-2 is relevant to melanocortin receptor and pigmentation-pathway research. This buyer-intent page is not a dosage guide, protocol, or medical recommendation. It exists to connect the product page with verification resources that a European laboratory buyer should check before placing an RUO order.

FAQ

Where can I buy Melanotan-2 for research in Europe?

Peptra Labs lists Melanotan-2 as RUO laboratory research material with EU dispatch, sealed labelled vials, and online CoA information where applicable. Review the product page, batch information, and research policy before ordering.

Is Melanotan-2 for human use?

No. Melanotan-2 from Peptra Labs is for laboratory research use only. It is not sold as a medicine, supplement, cosmetic ingredient, or veterinary product.

What should a Melanotan-2 buyer verify?

Check RUO status, vial label clarity, batch traceability, available purity testing, online CoA information where applicable, and whether the supplier avoids human-use claims.